文献速递重症综合管理与镇静镇痛

美国重症监护药学服务特征调查

Characterizing Critical Care Pharmacy Services Across the United States.
PubMed 文献 · Crit Care Explor · 2021-01-08
一句话结论美国ICU药师以直接临床服务为主,但夜间和周末服务少见,处方权限和远程医疗应用有限。

该调查向1220家美国机构的重症监护药师发放27题问卷,回收401份(应答率35.4%),代表493个ICU。中位每日ICU床位数为12,每ICU药师全职当量中位数为1。70.8%的ICU提供直接临床药学服务,药师每周随诊5天,患者与药师比中位数为17。常见活动包括用药史审核、不良事件评估和药物治疗管理,但夜间、周末服务及远程医疗较少,51.1%的药师拥有依赖型处方权,13.4%拥有独立处方权。

要点

  • 在493个ICU中,70.8%提供直接临床药学服务,药师每周随诊中位5天(IQR 4-5天)。
  • 患者与药师比中位数为17(IQR 12-26),每ICU药师全职当量中位数为1(IQR 1-1.5)。
  • 药师工作周中位50%用于直接ICU患者照护,10%教学,8%医嘱处理,5%非ICU直接照护。
  • 51.1%的药师拥有依赖型处方权(按方案或实践协议),13.4%拥有独立处方权。
  • 服务在夜间或周末较少提供,远程医疗很少使用;84-86.8%的受访者参与ICU或科室政策/指南制定。

适用人群与场景

  • 美国1220家机构的重症监护药师,最终分析401份调查代表493个ICU。
  • 调查对象为ICU药师,未明确排除标准。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 设计:27题预测试电子问卷调查,应答率35.4%(401/1220),代表493个ICU。
  • 中位每日ICU床位数12(IQR 6-20),每ICU药师全职当量中位数1(IQR 1-1.5)。
  • 70.8%的ICU提供直接临床药学服务;药师随诊中位5天/周(IQR 4-5),患者与药师比中位17(IQR 12-26)。
  • 工作周中位分布:直接ICU患者照护50%(IQR 40-60%),教学10%(IQR 8-16%),医嘱处理8%(IQR 5-18%),直接非ICU照护5%(IQR 0-20%),行政5%(IQR 2-10%),学术5%(IQR 0-10%),药品分发0%(IQR 0-5%)。
  • 常见临床活动占工作周百分比:用药史审核28.5%,不良事件评估27.6%,药物治疗评估26.1%、监测23.8%、管理21.4%。
  • 51.1%的药师拥有依赖型处方权,13.4%拥有独立处方权;教育服务最常见为在职培训(97.6%)和体验式培训(89%)。
  • 84-86.8%的受访者参与ICU或科室政策/指南制定,65.7%从事某种形式的学术活动。
  • 服务在夜间或周末较少提供,远程医疗很少使用。

证据类型、等级与局限

  • 证据类型:横断面问卷调查(预测试27题),应答率35.4%,可能存在无应答偏倚;原文未提供证据等级或推荐强度。
  • 局限:原文未明确说明抽样方法、应答者与非应答者差异,以及调查的验证细节。

对床旁实践的改变

  • 原文提示ICU药师职责多样,但夜间和周末服务可及性低,远程医疗应用少,处方权限有限;可据此评估本院药学服务覆盖时段与授权模式。
  • 适用人群为美国ICU药师,其他地区或机构类型需谨慎外推。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

UNLABELLED: Involvement of clinical pharmacists in the ICU attenuates costs, avoids adverse drug events, and reduces morbidity and mortality. This survey assessed services and activities of ICU pharmacists.

DESIGN: A 27-question, pretested survey.

SETTING: 1,220 U.S. institutions.

SUBJECTS: Critical care pharmacists.

INTERVENTIONS: Electronic questionnaire of pharmacy services and activities across clinical practice, education, scholarship, and administration.

MEASUREMENTS AND MAIN RESULTS: A total of 401 (response rate of 35.4%) surveys representing 493 ICUs were completed. Median daily ICU census was 12 (interquartile range, 6-20) beds with 1 (interquartile range, 1-1.5) pharmacist full-time equivalent per ICU. Direct clinical ICU pharmacy services were available in 70.8% of ICUs. Pharmacists attended rounds 5 days (interquartile range, 4-5 d) per week with a median patient-to-pharmacist ratio of 17 (interquartile range, 12-26). The typical workweek consisted of 50% (interquartile range, 40-60%) direct ICU patient care, 10% (interquartile range, 8-16%) teaching, 8% (interquartile range, 5-18%) order processing, 5% (interquartile range, 0-20%) direct non-ICU patient care, 5% (interquartile range, 2-10%) administration, 5% (interquartile range, 0-10%) scholarship, and 0% (interquartile range, 0-5%) drug distribution. Common clinical activities as a percentage of the workweek were reviewing drug histories (28.5%); assessing adverse events (27.6%); and evaluating (26.1%), monitoring (23.8%), and managing (21.4%) drug therapies. Services were less likely to occur overnight or on weekends. Telemedicine was rarely employed. Dependent prescriptive authority (per protocol or via practice agreements) was available to 51.1% of pharmacists and independent prescriptive authority was provided by 13.4% of pharmacists. Educational services most frequently provided were inservices (97.6%) and experiential training of students or residents (89%). Education of ICU healthcare members was provided at a median of 5 times/mo (interquartile range, 3-15 times/mo). Most respondents were involved with ICU or departmental policies/guidelines (84-86.8%) and 65.7% conducted some form of scholarship.

CONCLUSIONS: ICU pharmacists have diverse and versatile responsibilities and provide several key clinical and nonclinical services. Initiatives to increase the availability of services are warranted.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. MacLaren R, Roberts RJ, Dzierba AL, et al. Characterizing Critical Care Pharmacy Services Across the United States. Crit Care Explor. 2021. PMID: 33458690. doi:10.1097/CCE.0000000000000323

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。